Redpine Medical, a single-use endoscope maker based in Guangzhou, has reportedly raised “hundreds of millions” of renminbi in a Series C financing round led by Yuexiu Industrial Investment Fund. Other investors included Eight Roads, Guoju Venture Capital, Caixin Private Placement, and others. The proceeds will be used for manufacturing capacity upgrades, product iteration and upgrades, and domestic and overseas business development.
Company Background and Product Portfolio
Founded in 2015, Redpine Medical boasts its disposable endoscope, medical endoscope image processor, disposable therapeutic instruments under endoscope, and more. The company’s host platform is based on the independently developed IPS image processing system. Currently, it can be compatible with all kinds of mirrors in the department, including products already on the market, products under research, and iterative products, with good scalability.
Future Prospects and Strategic Use of Funds
The Series C financing round positions Redpine Medical to further enhance its manufacturing capabilities and product offerings. By investing in manufacturing upgrades and product iterations, Redpine aims to solidify its position as a leader in the disposable endoscope market, addressing significant unmet medical needs and improving patient outcomes through innovative solutions.-Fineline Info & Tech
